Related references
Note: Only part of the references are listed.CYP4F2 genetic variant alters required warfarin dose
Michael D. Caldwell et al.
BLOOD (2008)
A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
Gregory M. Cooper et al.
BLOOD (2008)
Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
David A. Flockhart et al.
GENETICS IN MEDICINE (2008)
Genetic determinants of response to warfarin during initial anticoagulation
Ute I. Schwarz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population:: comparison with other equations
Alan H. B. Wu et al.
PHARMACOGENOMICS (2008)
Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians
Paold Borgiani et al.
PHARMACOGENOMICS (2007)
Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - Rationale and perspectives
Tong Yin et al.
THROMBOSIS RESEARCH (2007)
Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen
Elizabeth A. Sconce et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose:: a prospective study
John F. Carlquist et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2006)
Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P4502C9 gene polymorphisms on warfarin dose requirements
CL Aquilante et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population
DL Veenstra et al.
PHARMACOGENETICS AND GENOMICS (2005)
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements:: proposal for a new dosing regimen
EA Sconce et al.
BLOOD (2005)
A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity
HY Yuan et al.
HUMAN MOLECULAR GENETICS (2005)
Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose
MJ Rieder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Common VKORC1 and GGCX polymorphisms associated with warfarin dose
M Wadelius et al.
PHARMACOGENOMICS JOURNAL (2005)
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
G D'Andrea et al.
BLOOD (2005)
Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
J Hirsh et al.
CHEST (2001)
Share Paper
